Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

Journal:

Nature Communications

Published:

2026-04-08

DOI:

10.1038/s41467-026-71452-6

Affiliations:

15

Authors:

30

Go to article

Institutions	Authors	Share
Karolinska Institute (KI), Sweden	14.666667 14.666667	0.49
Karolinska University Hospital, Sweden	7.000000	0.23
Capio St. Goran’s Hospital, Sweden	2.000000	0.07
Stockholm South General Hospital, Sweden	1.333333	0.04
SOLTI Breast Cancer Research Group, Spain	1.250000	0.04
UNC Lineberger Comprehensive Cancer Center, United States of America (USA)	1.000000	0.03
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain	0.583333	0.02
Hospital Clinic of Barcelona, Spain	0.583333	0.02
University of Barcelona (UB), Spain	0.583333	0.02
Vall d'Hebron University Hospital (HUVH), ICS, Spain	0.500000	0.02
Instituto Valenciano de Oncologia (IVO), Spain	0.500000	0.02

Interested in Oncology and Carcinogenesis?